Cargando…

Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research

The existing in vitro models for antitumor drug screening have great limitations. Many compounds that inhibit 2D cultured cells do not exhibit the same pharmacological effects in vivo, thereby wasting human and material resources as well as time during drug development. Therefore, developing new mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Lejia, Yang, Huayu, Wang, Yanan, Zhang, Xinyu, Jin, Bao, Xie, Feihu, Jin, Yukai, Pang, Yuan, Zhao, Haitao, Lu, Xin, Sang, Xinting, Zhang, Hongbing, Lin, Feng, Sun, Wei, Huang, Pengyu, Mao, Yilei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283506/ https://www.ncbi.nlm.nih.gov/pubmed/32582546 http://dx.doi.org/10.3389/fonc.2020.00878

Ejemplares similares

The Impacts of Systemic Immune-Inflammation Index on Clinical Outcomes in Gallbladder Carcinoma
por: Sun, Lejia, et al.
Publicado: (2020)

Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure
por: Yang, Huayu, et al.
Publicado: (2021)

Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model
por: Li, Changcan, et al.
Publicado: (2022)

Study on drug screening multicellular model for colorectal cancer constructed by three-dimensional bioprinting technology
por: Wang, Peipei, et al.
Publicado: (2023)

Current trends and research topics regarding liver 3D bioprinting: A bibliometric analysis research
por: Jin, Bao, et al.
Publicado: (2022)

Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis
por: Yang, Huayu, et al.
Publicado: (2019)

The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis
por: Xu, Gang, et al.
Publicado: (2019)

Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience
por: Sun, Lejia, et al.
Publicado: (2020)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy
por: Wang, Yanan, et al.
Publicado: (2022)

Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria
por: Xu, Wei, et al.
Publicado: (2017)

Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery
por: Sun, Lejia, et al.
Publicado: (2023)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China
por: Sun, Lejia, et al.
Publicado: (2020)

Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival
por: Sun, Lejia, et al.
Publicado: (2021)

Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric mice
por: Hu, Dandan, et al.
Publicado: (2018)

Patient-derived organoids: a promising model for personalized cancer treatment
por: Yang, Huayu, et al.
Publicado: (2018)

Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
por: Liao, Wenjun, et al.
Publicado: (2016)

Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection
por: Sun, Lejia, et al.
Publicado: (2021)

Controlling nutritional status score as a prognostic marker to predict overall survival in resected biliary tract cancers
por: Sun, Lejia, et al.
Publicado: (2021)

Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor
por: Sun, Lejia, et al.
Publicado: (2020)

Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering
por: Sun, Hang, et al.
Publicado: (2023)

An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular Carcinoma
por: Hu, Ying, et al.
Publicado: (2020)

Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma: A Meta-Analysis
por: Liao, Wenjun, et al.
Publicado: (2015)

Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison with traditional one-stage right hepatectomy
por: Zhang, Junwei, et al.
Publicado: (2020)

Association of a novel PKHD1 mutation in a family with autosomal dominant polycystic liver disease
por: Wang, Jiaru, et al.
Publicado: (2021)

Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up
por: Xu, Wei, et al.
Publicado: (2016)

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
por: Wang, Yunchao, et al.
Publicado: (2022)

The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
por: Jin, Bao, et al.
Publicado: (2021)

Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer
por: Ke, Xindi, et al.
Publicado: (2021)

Alteration in gut microbiota caused by time‐restricted feeding alleviate hepatic ischaemia reperfusion injury in mice
por: Ren, Jinjun, et al.
Publicado: (2018)

Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma
por: Luo, Mei, et al.
Publicado: (2021)

Tenofovir over Entecavir on Hepatocellular Carcinoma Prevention: Potential Mechanisms and Suitable Population
por: Huang, Yongfa, et al.
Publicado: (2022)

Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma
por: Bao, Yingying, et al.
Publicado: (2022)

Public Psychosocial and Behavioral Responses in the First Wave of COVID-19 Pandemic: A Large Survey in China
por: Yang, Huayu, et al.
Publicado: (2021)

The diagnostic and prognostic role of RhoA in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2019)

Diagnosis and treatment of a diaphragmatic pheochromocytoma: A case report
por: Wu, Xiangan, et al.
Publicado: (2020)

A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma
por: Yang, Hua, et al.
Publicado: (2021)

A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma
por: Qi, Tengfei, et al.
Publicado: (2021)

Highlights of constructing liver-relevant in vitro models with 3D bioprinting
por: Zhang, Jiangang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r9a9s4a274echj8l85apkuqq6g